Boston Scientific is buying Penumbra for $14.5 billion to get into the business of removing blood clots
Up next
Author


Penumbra’s stock was up about 12% after the deal was announced Thursday morning.

You May Also Like
Here’s what junk bonds are saying now about the value of Treasury bonds

Here’s what junk bonds are saying now about the value of Treasury bonds

High-yield bond holders aren’t asking for much of a premium above ultra-safe…
Fresh debt from JPMorgan, Morgan Stanley draws warm reception from investors in hopeful sign

Fresh debt from JPMorgan, Morgan Stanley draws warm reception from investors in hopeful sign

As big Wall Street banks issue billions in new debt, yield spreads…
‘Frenzied as ever’ — the Dan Ives-led Worldcoin treasury purchase is only latest example of market madness

‘Frenzied as ever’ — the Dan Ives-led Worldcoin treasury purchase is only latest example of market madness

The 3,000% surge in Eightco Holdings on the purchase of a digital…
Chris Pratt and Katherine Schwarzenegger relist luxury L.A. home for $20 million

Chris Pratt and Katherine Schwarzenegger relist luxury L.A. home for $20 million

The couple have put their sprawling Pacific Palisades, Calif., mansion back on the market…